DIR Fees White Paper Highlights SPT Week in Review


Top news of the week from Specialty Pharmacy Times.

5. Monitoring Drug Interactions in Aging Patients With HIV

How pharmacists can reduce polypharmacy and potentially inappropriate prescribing among the aging HIV population. Read more.

4. New Treatment Approach Could Lead to a Functional HIV Cure

A derivative of a natural compound could stop HIV replication and prevent a viral rebound. Read more.

3. Gene Therapy-Immunotherapy Combination Could Reverse Multiple Sclerosis

Combination therapy found to reverse multiple sclerosis in mice models. Read more.

2. Biosimilars Could Save $54 Billion Over the Next Decade

The emergence of biosimilars will reduce spending on biologics by 3% through 2027. Read more.

1. White Paper: DIR Fees Simply Explained

This paper examines the use and implications of direct and indirect remuneration (DIR) fees and potential strategies to overcome the challenges that accompany DIR fees. Read more.

Related Videos
male pharmacist using digital tablet during inventory in pharmacy | Image Credit: sofiko14 - stock.adobe.com
Pharmacist holding medicine box in pharmacy drugstore. | Image Credit: I Viewfinder - stock.adobe.com
Pharmacy Drugstore Checkout Cashier Counter | Image Credit: Gorodenkoff - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Capsules medicine and white medicine bottles on table | Image Credit: Satawat - stock.adobe.com
Human cell or Embryonic stem cell microscope background | Image Credit: Anusorn - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Biosimilar pharmaceutical drug bottle on blue background. | Image Credit: Carl - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.